What Clinical Outcomes Are Monitored during Immunogenicity Assessment of Hormonal Peptides?
Monitoring immunogenicity involves tracking therapy effectiveness, patient safety, and changes in the peptide's behavior in the body.
HRTioAugust 2, 2025